Search results
CRYOcheck Factor II (Prothrombin) Deficient Plasma, frozen
Deficient substrate for clot-based factor II assays.
Factor II (Prothrombin) Deficient Plasma
Measurement of factor II (FII / prothrombin) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human prothrombin deficient plasma is required.
Factor II (Prothrombin) Deficient Plasma
Measurement of Factor II (FII / prothrombin) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human prothrombin deficient plasma is required.
Platelet lysate 4, Human
High purity preparation, in the tetrameric form, tested for its anti-heparin activity. In presence of heparin, this product offers an optimized binding capacity for heparin dependent antibodies developed in HIT (heparin induced thrombocytopenia).
Protac® Protein C Activator
For activation of protein C.
vWF Deficient Plasma
For any in vitro protocol or research study where a source of vWF deficient plasma is required.
Protein S Deficient Plasma
For any in vitro protocol or research study where a source of human protein S deficient plasma is required.
BIOPHEN Antithrombin (anti-IIa)
Diagnosis of congenital or acquired antithrombin deficiencies. Measurement of AT activity in biological milieu or purified fractions.
Plasminogen, Human
Recommended for any research study on fibrinolysis.
FIBRIPHEN 5
Measurement of fibrinogen in plasma. Detection of low fibrinogen concentrations. Detection of elevated fibrinogen concentrations (> 4g/L): In clinical situations associated with inflammation Risk factor for cardiovascular disease and thrombosis Hypofibrinogenemia, mainly associated with severe liver disease, and excessive consumption of fibrinogen (DIC, hyperfibrinolysis). Numerous variants of fibrinogen described, associated to asymptomatic cases, or to cases with bleeding and/or thrombosis.